Author | Lightnews

BioKnow @bioknow.bsky.social · May 14

Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷

Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!

Connect, innovate & shape the future of biotech!

Register now: buff.ly/65vWn7D

1

BioKnow @bioknow.bsky.social · Mar 18

Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷

Key Speakers include Jakob E. Larsen (Novo), Jimmy Toulas (Pfizer), Thomas Balkizas (Microsoft), and more!

Connect, innovate & shape the future of biotech!

Register now: tinyurl.com/sscbx4nn

London Biotechnology Show

The London Biotechnology Show aims to accentuate the progress of biotechnology in the United Kingdom and around the world by bringing together leading industry experts and key stakeholders from the en...

tinyurl.com

1

BioKnow @bioknow.bsky.social · Mar 18

Top Pharma Companies by 2024 Pipeline Size 🧬

Check out the latest data from the Citeline Pharma R&D Review 2024, showcasing the top global pharmaceutical companies ranked by the number of drug candidates in their pipeline. 🏆

#biotech #biopharma #pharma

2

BioKnow @bioknow.bsky.social · Mar 17

New Biologics Companies Launched👇

2024 saw exciting new compaies launched as shown below in the incredible lineup of new and emerging biologic companies in 2024, spanning cell therapy, gene therapy, RNA-based therapeutics, antibodies, and more.

Credit/Source: biopharma

#celltherapy #biopharma

2

BioKnow @bioknow.bsky.social · Mar 17

🚨 BREAKING: Scientists Achieve Removal of Extra Chromosome in Down Syndrome! 🧬

Major milestone as researchers have used CRISPR-Cas9 technology to remove the extra copy of chromosome 21 in human cells—marking a significant step forward in genetic research!

🔗 Read the full article: buff.ly/yC4CZji

BioKnow @bioknow.bsky.social · Mar 13

Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷

Connect, innovate & shape the future of biotech!

Register now: tinyurl.com/sscbx4nn

1

BioKnow @bioknow.bsky.social · Mar 4

FREE Biotech Newsletter:
Your quick way to the latest breakthroughs...

90% of our subscribers report feeling more informed about biotech developments.
Join a community of 18,000+ biotech enthusiasts who share insights and updates weekly!

Join here: lnkd.in/decTJM6Q

#Biotech #Biopharma

Newsletter Sign Up

dashboard.mailerlite.com

1

BioKnow @bioknow.bsky.social · Mar 4

𝐀𝐥𝐥 𝐜𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐈𝐦𝐦𝐮𝐧𝐞 𝐒𝐲𝐬𝐭𝐞𝐦:

The immune system is a complex network of cells, tissues, and organs that defends the body against pathogens like bacteria, viruses, fungi, and parasites.

Source: BioTecNika

#immunology #oncology #biotech #celltherapy

1

BioKnow @bioknow.bsky.social · Mar 4

Companies Focused on Neuroinflammatory Targets 👇

72 biopharmaceutical companies below categorised by Preclinical to Phase III and based in therapeutic areas such as CNS, Gene Therapy and iPSCs.

- NLPR 3
- PGRN
- TREM2
- Other

#neurology #biotech #genetherapy #biopharma

1

BioKnow @bioknow.bsky.social · Feb 22

Biopharma M&A Heats Up:
Top 20 Deals by Valuation (2023-2025 YTD) 💰💊

The biopharma industry continues its M&A momentum, with oncology, CNS, and I&I emerging as the most sought-after therapeutic areas.

Credit/Source: Bloomberg & Deutsche Bank

#biotech #biopharma #pharmaceuticals #neurology

2

BioKnow @bioknow.bsky.social · Feb 22

Visualizing smLiveFISH-labelled MAP1B RNAs in Live Cells using CRISPR-csm.

#genetherapy #biotech #biopharma #crispr

1

BioKnow @bioknow.bsky.social · Feb 18

Save the date! The London Biotechnology Show returns on 18-19 June 2025 at ExCeL London. 📷

Connect, innovate & shape the future of biotech!

Register now: tinyurl.com/sscbx4nn

BioKnow @bioknow.bsky.social · Feb 18

Top-Selling Pharma Medicines 👇

>> Mounjaro (Lilly): Achieved $12B annualized sales in just 9 quarters post-FDA approval (May 2022).
>> Dupixent (Regeneron/Sanofi): Surpassed $15B in annualized sales.

Source: Maven Bio

#obesity #oncology

1

BioKnow @bioknow.bsky.social · Feb 18

𝗔𝘂𝘁𝗶𝘀𝗺 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 👇

There are no hashtag FDA approved medications that directly target autism’s primary symptoms.

Source: Maryam Daneshpour / clinicaltrials.gov

#autism #neurology #biotech #biopharma

ClinicalTrials.gov

Study record managers: refer to the Data Element Definitions if submitting registration or results information.

clinicaltrials.gov

BioKnow @bioknow.bsky.social · Feb 17

🚨 Exciting News! 🚨

BioKnow is thrilled to announce our partnership with Scientex Conferences for the International Conference on Cardiology and Cardio Care, happening November 28-29, 2025, in Paris, France! 🇫🇷

🔗 Learn more: lnkd.in/gkWrZ5yN

#CardiologyConference #CardioCare2025 #CardiovascularCare

This link will take you to a page that’s not on LinkedIn

lnkd.in

BioKnow @bioknow.bsky.social · Feb 17

Algae Biotechnology Market 👇

Here’s a quick look at key algae biotechnology companies by region—spanning North America, Europe, and Asia—as highlighted in this visual by BioKnow. 🚀

#algae #biotech #biopharma

1

BioKnow @bioknow.bsky.social · Feb 16

Global Pharma Leaders of 2024:
A Billion-Dollar Industry on the Rise 👇

🔹 Johnson & Johnson leads the pack with an impressive $88.8 billion in revenue.
🔹 Pfizer, Merck, and AbbVie follow closely, with revenues exceeding $55 billion each.

#pharma #biopharma

BioKnow @bioknow.bsky.social · Feb 13

Global ADC Market 👇

The #ADC market is experiencing rapid growth, with forecasts indicating a global market size exceeding $18B by 2025, driven by the increasing adoption of targeted #cancer #therapies and the success of key ADCs.

Credits: PharmaSights, Alexander Bonebakker

1

BioKnow @bioknow.bsky.social · Feb 12

2024 FDA Oncology Approvals ✅

The FDA approved 50 novel drugs last year, with oncology and hematology leading. A key approval was Datroway (datopotamab deruxtecan) for metastatic HR-positive, HER2-negative breast cancer.

Credit: Maryam Daneshpour

#oncology #immunotherapy

BioKnow @bioknow.bsky.social · Feb 11

Radiopharma Market 👇

The graph shows a list of FDA-approved radiopharmaceuticals in compliance with USP <825> standards.

The #nuclear medicine market is experiencing rapid growth and projected to reach USD $13.10B by 2032, with a CAGR of 9.10%.

#oncology #radiopharma

BioKnow @bioknow.bsky.social · Feb 10

🩸 The Evolution of Immune Cell Discoveries & Technologies! 🔬✨

From the first observation of blood cells in 1658 to the identification of steroid-producing Th2 cells in 2015, the study of immune cells has transformed dramatically! 🚀

CREDIT: Ayesha Tabassum

Reposted by BioKnow

Kevin M. Kruse @kevinmkruse.bsky.social · Feb 9

Whenever you hear someone sneer about scientific research that seems useless to them — “they’re studying the spit of lizards?!” — remind them that’s exactly how we got Ozempic.

globalnews.ca/news/9793403...

How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca

In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.

globalnews.ca

520 7.9K 30K

Reposted by BioKnow

Nature @nature.com · Feb 6

Nature research paper: A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

https://go.nature.com/4gtHiuX

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma - Nature

A phase I trial of a neoantigen-targeting personalized cancer vaccine led to durable and polyfunctional T cell responses and antitumour recognition, and was associated with no recurrence in patients with high-risk clear cell renal cell carcinoma.

go.nature.com

2 7 44

Reposted by BioKnow

Nature @nature.com · Feb 7

Nature research paper: Millihertz oscillations near the innermost orbit of a supermassive black hole

https://go.nature.com/3WNcI8w

Millihertz oscillations near the innermost orbit of a supermassive black hole - Nature

A millihertz frequency X-ray quasi-periodic oscillation has been observed near the innermost orbit of an actively accreting supermassive black hole and its frequency has evolved significantly over 2 years, a phenomenon that is difficult to explain with existing models.

go.nature.com

3 21

BioKnow @bioknow.bsky.social · Feb 9

FREE #Biotech Newsletter: dashboard.mailerlite.com/forms/996595...
Your gateway to the latest breakthroughs, so you're never left behind.

🔔 Be at the Forefront with critical #updates and #insights.
🔥 Don’t Miss a Beat in the evolving world of biotech!

Newsletter Sign Up

dashboard.mailerlite.com